The human cytomegalovirus (HCMV) is the most important infectious cause of congenital
abnormalities and also of infectious complications of transplantation. The biology of the …

Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are human herpesviruses (HHV) that
are common in humans. Primary EBV and CMV infections mostly are asymptomatic but can …

Human cytomegalovirus (HCMV) infection is common and affects between 40–100% of the
worldwide population. However, the majority of cases are asymptomatic and when severe …

Survival following liver transplantation has changed dramatically owing to improvement in
surgical techniques, peri-operative care and optimal immunosuppressive therapy. Post-Liver …

Everolimus‐facilitated reduced‐exposure tacrolimus (EVR+ rTAC) at 30 days after liver
transplantation (LT) has shown advantages in renal preservation. This study evaluated the …

Introduction and objectives The success of direct-acting antivirals (DAA) has transformed the
management of hepatitis C virus (HCV) infection and has led to the expansion of the …

Human cytomegalovirus (HCMV) is a near ubiquitous herpesvirus that relies on host cell
metabolism for efficient replication. Although it has been shown that HCMV requires …

Cytomegalovirus (CMV) infection is a common complication of liver trans-plantation in
children. The CMV serostatus of recipients and donors is the primary risk factor, and …

Human cytomegalovirus (CMV) remains a major cause of mortality and morbidity in human
liver transplant recipients. Anti-CMV therapeutics can be used to prevent or treat CMV in …

Despite prevention strategies, cytomegalovirus (CMV) remains a common infection in
pediatric solid organ transplant recipients (SOTR). We sought to determine the frequency …